Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 182, pseudogene (RNU6-182P) is annotated as a pseudogene—a nonfunctional RNA copy—related to the U6 small nuclear RNA (snRNA) family[2]. U6 snRNAs are integral to spliceosomal activity and pre-mRNA splicing; however, pseudogenes like RNU6-182P do not encode functional snRNAs[2][1]. Instead, pseudogenes may exert possible regulatory influences at the RNA level—such as acting as competing endogenous RNAs, antisense transcripts, or through sequestration of microRNAs—but such roles have not been specifically demonstrated for RNU6-182P[4]. Evidence for significant direct therapeutic targeting or established biomarker use is lacking. This molecule is not considered a therapeutic target or a biologically active receptor, enzyme, transporter, or similar druggable gene. Its annotation as a pseudogene means it is likely nonfunctional, though the broader class of pseudogenes can, in some cases, play subtle roles in gene expression regulation[4][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 182, pseudogene (RNU6-182P).